Results 181 to 190 of about 87,295 (197)
Some of the next articles are maybe not open access.
Hematologic Manifestations of Liver Disease
Seminars in Hematology, 2013The liver plays a key role in both protein biosynthesis and lipid metabolism. As a result, hepatic synthetic dysfunction can have adverse effects on both cellular and soluble components of blood. Anemia may occur due to the hemolysis of acanthocytes (spur cells), which is ultimately due to abnormal lipid composition of the red blood cell membrane ...
openaire +3 more sources
2019
Polycythemia vera (PV) is a clonal myeloproliferative disease characterized by erythrocytosis. This is pathologically characterized by the simultaneous proliferation of erythroid, granulocyte, and megakaryocytes in bone marrow. The number and the capacity of erythrocyte are significantly increased in clinical characteristics, accompanied by neutrophils
Amin Shi, Nuerguli Maimaiti, Lin Wang
openaire +2 more sources
Polycythemia vera (PV) is a clonal myeloproliferative disease characterized by erythrocytosis. This is pathologically characterized by the simultaneous proliferation of erythroid, granulocyte, and megakaryocytes in bone marrow. The number and the capacity of erythrocyte are significantly increased in clinical characteristics, accompanied by neutrophils
Amin Shi, Nuerguli Maimaiti, Lin Wang
openaire +2 more sources
Neurologic Manifestations of Hematologic Disease
Neurologic Clinics, 1989Hematologic diseases may affect the nervous system. Abnormalities in the cellular components, impaired flow, abnormal clotting, or tendency to bleed may all produce neurologic symptoms and signs. A systematic approach to these etiologies is important.
Jack E. Riggs, Massey Ew
openaire +3 more sources
Pulse Steroids in Hematologic Diseases
Hospital Practice, 1985Experience with megadose steroid therapy in immune-mediated dyscrasias indicates that the modality can suppress destructive immune reactivity quickly and dramatically, without significant adverse effects. Pulse steroids are currently being given only for severe and intractable disease; further investigation is needed to determine their value in less ...
openaire +3 more sources
Hematological manifestations of celiac disease
Scandinavian Journal of Gastroenterology, 2012Celiac disease, an autoimmune disease once thought to be uncommon, is now being increasingly identified. Our improved diagnostic modalities have allowed us to diagnose more and more patients with atypical symptoms who improve on gluten-free diet (GFD).
Houssam Halawi +4 more
openaire +3 more sources
Hematologic Manifestations of Systemic Disease
Pediatric Clinics of North America, 1972The wide range of systemic disorders covered in this article includes infections, collagen disease, congenital heart disease, liver disease, kidney disease, endocrine disease, inherited disorders, and poisoning.
openaire +3 more sources
Oxymetholone and Hematologic Disease
Annals of Internal Medicine, 1973Excerpt To the editor: With regard to the comment by Dr. C. R. Kjeldsberg (Ann Intern Med79:288, 1973), that the report of Delamore and Geary (1) constitutes the only association of leukemia with o...
openaire +2 more sources
Hematologic Complications of Rheumatic Disease
Hematology/Oncology Clinics of North America, 1987The systemic rheumatic diseases are commonly complicated by hematologic abnormalities. Five frequently encountered and clinically relevant complications are reviewed. They include the anemia of chronic disease, neutropenia, autoimmune thrombocytopenic purpura, the lupus inhibitor, and hematologic malignancies.
openaire +3 more sources
Hematologic Disorders and Heart Disease
Postgraduate Medicine, 1968Anemia, polycythemia, leukemia and sickle cell disease can affect heart function. Anemic patients may have tachycardia, bounding pulse and angina. With polycythemia, patients may become hypertensive because of increased peripheral resistance.Leukemia cells can infiltrate the myocardium and cause heart failure or arrhythmias. Pain, fever, murmurs, joint
openaire +3 more sources
Progress in the Chemotherapy of Hematologic Diseases
2015Progress in the chemotherapy of Hodgkin's disease and experimental therapeutic, pharmacologic, and clinical studies of the antitumor antibiotic, adriamycin, are presented in this abstract. In patients with disseminated Hodgkin's disease, the combination chemotherapy program (MOPP) produces a significant increase in the complete remission rate. This has
openaire +3 more sources